Literature DB >> 33469171

Dendritic cells and monocyte subsets in children with Gaucher disease.

Asmaa M Zahran1, Khaled Saad2, Alam-Eldin M Abdallah3, Eman F Gad3, Yasser F Abdel-Raheem3, Zeinab Albadry M Zahran4, Eman M Nagiub Abdelsalam4, Amira Elhoufey5,6, Thamer Alruwaili7, Khaled Hashim Mahmoud3, Khalid I Elsayh3.   

Abstract

BACKGROUND: There are minimal data on the frequencies of monocyte subsets and dendritic cells (DCs) in children with Gaucher disease (GD), as nearly all previous studies have involved adult patients. Consequently, we aimed to describe the changes in these cell subpopulations in children with GD type 1 who were on regular enzyme replacement therapy (ERT).
METHODS: This case-control study included 25 children with GD1 and 20 healthy controls. All participants underwent investigations such as complete blood count and flow cytometric assessment of DC and monocyte frequencies and phenotype.
RESULTS: We found that GD1 children had significantly reduced percentages of both types of DCs, i.e., plasmacytoid DCs and myeloid DCs, compared to the control group. There was also a significant reduction in absolute monocyte numbers and percentage of classical monocyte. Moreover, the GD1 children had higher frequencies of non-classical and intermediate monocytes than the control group.
CONCLUSIONS: Our results so far indicate that, when compared to the control group, the GD1 children had significantly reduced total and classical monocyte, with significantly decreased frequencies for both types of DCs. These changes can contribute to immunological abnormalities in pediatric patients with GD1. IMPACT: Children with Gaucher disease type 1 (GD1) have significantly reduced total and classical monocyte frequencies, with decreasing percentages for both types of dendritic cells. GD1 children had significantly reduced frequencies of myeloid and plasmacytoid dendritic cells as compared to the controls. The GD1 children also had significant changes in monocyte subsets when compared to the controls. Our results show that monocytes and dendritic cells' significant changes could contribute to immunological abnormalities in pediatric patients with GD1.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33469171     DOI: 10.1038/s41390-020-01300-w

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.

Authors:  Y Burstein; V Zakuth; G Rechavi; Z Spirer
Journal:  J Clin Lab Immunol       Date:  1987-07

2.  Down-regulation of Regulatory T-cells in Children With Gaucher Disease Under Enzyme Replacement Therapy.

Authors:  Asmaa M Zahran; Khaled Saad; Mohamed Gamil Abo-Elela; Esraa M Eloseily; Eman F Gad; Amir M Abo Elgheet; Rasha R Mahmmoud; Mervat A M Youssef; Mona M Abdelmeguid; Bahaa Hawary; Sanaa F Darwish; Amira Elhoufey; Khalid I Elsayh
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  2 in total
  1 in total

1.  Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease.

Authors:  Asmaa M Zahran; Khaled Saad; Khalid I Elsayh; Madleen Adel A Abdou; Amir M Abo-Elgheet; Esraa M Eloseily; Shaimaa M Khalaf; Shabaan Sror; Faisal-Alkhateeb Ahmad; Amira Elhoufey; Aliaa Ghandour; Naglaa S Osman
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.